Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-01
2005-03-01
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S415000, C514S443000, C514S469000, C548S503000, C549S466000, C549S467000, C549S471000, C549S055000
Reexamination Certificate
active
06861444
ABSTRACT:
Compounds of the general formula (I):or a salt thereof, wherein R1is hydrogen, hydroxyl or halogen; R2is NHSO2CH3, SO2NHCH3or the like; R5and R6each independently is hydrogen, C1-6alkyl, optionally substituted phenyl or optionally substituted benzyl; X is NH, sulfur, oxygen or methylene; Y is oxygen, NR7, sulfur, methylene or a bond; and * represents an asymmetric carbon atom. The compounds are useful as a medicine for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances.
REFERENCES:
patent: 4338333 (1982-07-01), Ainsworth et al.
patent: 4816457 (1989-03-01), Baldwin et al.
patent: 5541197 (1996-07-01), Fisher et al.
patent: 5767133 (1998-06-01), Dow et al.
patent: 5859044 (1999-01-01), Dow et al.
patent: 5977124 (1999-11-01), Dow
patent: 6037362 (2000-03-01), Miyoshi et al.
patent: 6172099 (2001-01-01), Miyoshi et al.
patent: 6187809 (2001-02-01), Miyoshi et al.
patent: 24 29 253 (1976-01-01), None
patent: 0 171 702 (1986-02-01), None
patent: 0 455 006 (1991-11-01), None
patent: 0 659 737 (1995-06-01), None
patent: 1 142 883 (2001-10-01), None
patent: 1 174 425 (2002-01-01), None
patent: 1 238 973 (2002-09-01), None
patent: 1 565 080 (1980-04-01), None
patent: A 55-53262 (1980-04-01), None
patent: A 58-41860 (1983-03-01), None
patent: A 8-165276 (1996-06-01), None
patent: WO 9635670 (1996-11-01), None
patent: WO 9725311 (1997-07-01), None
Barrie C.C. Cantello et al., “BRL 35135,” Drugs of the Future, V. 16, 1991, pp. 797-800.
David C. Humber et al., “Disodium(R,R)-5- [2- [ [2- (3-Chlorophenyl) -2-hydroxyethyl] -amino]propyl] -1,3-benzodioxole-2,2-dicarboxylate (CL 316,243),” J. Med. Chem., V. 35, 1992, pp. 3081-3084.
Ikuta Shunichi
Miyoshi Shiro
Ogawa Kohei
Asahi Kasei Pharma Corporation
McKane Joseph K.
Small Andrea D.
Young & Thompson
LandOfFree
Bicyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3380080